RxDoctor Payments DataLook up a doctor →

Gintaras Aukstuolis

Psychiatry · Little Rock, ARNPI 1811084221

Payments from drug & device makers

$6,574,559in general payments, 2019–2025

Across 568 payments — averaging $11,575 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.4M
  • Sunovion Pharmaceuticals Inc.$1.7M
  • AbbVie$1.2M
  • Alkermes, Inc.$468K
  • Teva Pharmaceuticals USA, Inc.$276K
  • Acadia Pharmaceuticals Inc$264K
  • plus $317K from 11 others
$3,689in research payments, 2019–2025

Across 17 payments — averaging $217.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
  • AbbVie$879

What the payments were for

  • Consulting fees$3,30089%
  • Food & beverage$40411%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,574,559 in reported general payments places this provider in the 95th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Other psychiatry in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →